Min Tang

3.5k citations
71 papers · 2.2k indexed · 1 hit paper · h-index 25
Topics
Viral-associated cancers and disorders (25 papers)Lymphoma Diagnosis and Treatment (9 papers)RNA modifications and cancer (8 papers)

In The Last Decade

Min Tang

67 papers receiving 2.2k citations

Hit Papers

Emerging roles of lipid metabolism in cancer metastasis20172026202020232017100200300400

Peers

Min Tang
Comparison fields: 5 of 119
  • Molecular Biology 1.2k
  • Cancer Research 763
  • Oncology 724
  • Immunology 419
  • Epidemiology 290
Replace Marc O. Warmoes with:
Marc O. Warmoes United States
Chi‐Long Chen Taiwan
Suimin Qiu United States
Xiyun Deng China
Chao Ni China
Ioannis S. Pateras Greece
Che-Pei Kung United States
Kefei Yuan China
Naoya Sakamoto Japan
Hua‐chuan Zheng China
Min Tang relative to Marc O. Warmoes United States Marc O. Warmoes's profile →
Citations per field
00.5×1.5×1.8×
Marc O. Warmoes · 1×
Citations per year

Countries citing papers authored by Min Tang

Since Specialization
Citations

This map shows the geographic impact of Min Tang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Min Tang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Min Tang more than expected).

Fields of papers citing papers by Min Tang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Min Tang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Min Tang. The network helps show where Min Tang may publish in the future.

Co-authorship network of co-authors of Min Tang

This figure shows the co-authorship network connecting the top 25 collaborators of Min Tang. A scholar is included among the top collaborators of Min Tang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Min Tang. Min Tang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 7
3 24
4 1
5 10
6 1
7 2
8 14
9 15
10 23
11 38
12 82
13 62
14
Emerging roles of lipid metabolism in cancer metastasisbreakdown →
499
15 15
16 36
17 39
18 18
19 78
20 4

About Min Tang

Min Tang is a scholar working on Oncology, Computer Graphics and Computer-Aided Design and Immunology, having authored 71 papers that have together received 2.2k indexed citations. Recurring topics across this work include Viral-associated cancers and disorders (25 papers), Lymphoma Diagnosis and Treatment (9 papers) and RNA modifications and cancer (8 papers). The work is most often cited by research in Cancer Research (763 citations), Oncology (724 citations) and Immunology (419 citations). Min Tang has collaborated with scholars based in China, United States and Saudi Arabia. Frequent co-authors include Ya Cao, Xiangjian Luo, Zheqiong Tan, Lifang Yang, Namei Li, Ann M. Bode, Can Cheng, Lanbo Xiao, Zigang Dong and Yueshuo Li. Their work appears in journals such as PLoS ONE, Scientific Reports and FEBS Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026